Geron Announces Presentations at American Society of Hematology Annual Meeting
05 nov. 2015 09h03 HE
|
Geron Corporation
MENLO PARK, Calif., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that three abstracts describing clinical and non-clinical data on imetelstat have been...
Geron Announces Conference Call to Discuss Third Quarter 2015 Financial Results
29 oct. 2015 07h30 HE
|
Geron Corporation
MENLO PARK, Calif., Oct. 29, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the third quarter ended September 30, 2015, on Thursday, November 5,...
Geron to Present at the BIO Investor Forum
13 oct. 2015 07h30 HE
|
Geron Corporation
MENLO PARK, Calif., Oct. 13, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at...
Geron Announces Initiation of Janssen Phase 2 Clinical Trial of Imetelstat in Myelofibrosis
16 sept. 2015 07h30 HE
|
Geron Corporation
MENLO PARK, Calif., Sept. 16, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced the dosing of the first patient in a Phase 2 clinical trial to evaluate imetelstat in...
Dual Publications in the New England Journal of Medicine Highlight Transformative Potential of Imetelstat in Hematologic Myeloid Malignancies
02 sept. 2015 17h01 HE
|
Geron Corporation
MENLO PARK, Calif., Sept. 02, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced the publication of two papers in The New England Journal of Medicine (NEJM) in which the...
Geron Corporation Reports Second Quarter 2015 Financial Results
05 août 2015 16h05 HE
|
Geron Corporation
MENLO PARK, Calif., Aug. 05, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the second quarter ended June 30, 2015. Second Quarter 2015 Results For...